Pulmonary aspergillosis in critically ill patients with Coronavirus Disease 2019 (COVID-19) - CNRS - Centre national de la recherche scientifique Accéder directement au contenu
Article Dans Une Revue Medical Mycology Année : 2021

Pulmonary aspergillosis in critically ill patients with Coronavirus Disease 2019 (COVID-19)

Résumé

Occurrence of putative invasive pulmonary aspergillosis was screened in 153 consecutive adult intensive care unit (ICU) patients with respiratory samples addressed for mycological diagnosis during a 6-week period at the emergence of coronavirus disease 2019 (COVID-19) pandemic. Positive severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) polymerase chain reaction (PCR) was observed for 106 patients (69.3%). Nineteen of them (17.9%) with positive Aspergillus results were considered as having putative invasive pulmonary aspergillosis. These observations underline the risk of pulmonary aspergillosis in COVID-19 patients, even in patients not previously known to be immunosuppressed, advocating active search for Aspergillus infection and prompt antifungal treatment. Standardized surveillance protocols and updated definitions for ICU putative invasive pulmonary aspergillosis are needed. LAY ABSTRACT: Adult ICU patients with respiratory samples addressed for mycological diagnosis were screened during the emergence of COVID-19 pandemic. Positive SARS-CoV-2 PCR was observed for 106 patients, nineteen of them (17.9%) having aspergillosis. This underlines the risk of aspergillosis in COVID-19 patients.
Fichier sous embargo
Fichier sous embargo
Date de visibilité indéterminée

Dates et versions

inserm-03274424 , version 1 (30-06-2021)

Identifiants

Citer

Didier Dupont, J. Menotti, J. Turc, C. Miossec, F. Wallet, et al.. Pulmonary aspergillosis in critically ill patients with Coronavirus Disease 2019 (COVID-19). Medical Mycology, 2021, 59 (1), pp.110-114. ⟨10.1093/mmy/myaa078⟩. ⟨inserm-03274424⟩
62 Consultations
19 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More